Miltenyi Biomedicine
Hans-Juergen Fuelle is an experienced professional in the field of regulatory affairs, with a background in medicine, biochemistry, and regulatory science. Hans-Juergen has held various leadership roles at companies such as Novartis and Miltenyi Biomedicine, overseeing global regulatory strategies for gene therapies and drug portfolios. Prior to their industry career, Hans-Juergen was involved in academic research at prestigious institutions focusing on vision and olfaction. Fuelle holds multiple degrees in medicine, biochemistry, and regulatory science from universities in Germany and the United States.
Miltenyi Biomedicine
2 followers
Miltenyi Biomedicine is a biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bring cancer treatments and regenerative therapies to patients with unmet medical needs worldwide. We work in partnership with physicians and other healthcare providers to expand access to new therapies. Our clinical research program includes: CAR T, CAR NK, our proprietary Adapter CAR™ and induced pluripotent stem cells (iPSC) technologies. For more information, please visit our website at www.miltenyibiomedicine.com.